Package 67877-732-97

Brand: lacosamide oral solution

Generic: lacosamide oral solution
NDC Package

Package Facts

Identity

Package NDC 67877-732-97
Digits Only 6787773297
Product NDC 67877-732
Description

465 mL in 1 BOTTLE (67877-732-97)

Marketing

Marketing Status
Marketed Since 2022-05-20
Brand lacosamide oral solution
Generic lacosamide oral solution
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c4d07291-0152-4092-a339-3edee132ef09", "openfda": {"nui": ["N0000008486"], "upc": ["0367877732954"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["4ae87834-05d8-43c8-aaa3-78047d4a573c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "200 mL in 1 BOTTLE (67877-732-95)", "package_ndc": "67877-732-95", "marketing_start_date": "20220520"}, {"sample": false, "description": "465 mL in 1 BOTTLE (67877-732-97)", "package_ndc": "67877-732-97", "marketing_start_date": "20220520"}], "brand_name": "Lacosamide Oral Solution", "product_id": "67877-732_c4d07291-0152-4092-a339-3edee132ef09", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-732", "dea_schedule": "CV", "generic_name": "Lacosamide Oral Solution", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA214672", "marketing_category": "ANDA", "marketing_start_date": "20220520", "listing_expiration_date": "20261231"}